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Among thé four species of malarial parasites which infect humans, Plasmodium
falciparum is responsible for thé most sévère cases. Nowadays, thé increasing résistance of
this parasite against thé most widely used antimalarial drugs makes it urgent to find
alternative compounds (1).
In considération of thé many biological properties of alkaloids, and particularly of
quinine (which remains an important antimalarial drug), it was not surprising that a séries of
indolomonoterpenic alkaloids, mainly isolated from Strychnos usambarensis Gilg and from
Strychnos icaja Baill., thé latter used in traditional medicine from Central Africa to treat
chronic malaria, présent antiplasmodial properties (2). Therefore, thèse plants, both of which
contain a complex mixture of thèse indolomonoterpenic alkaloids, were subjected as well as
other species of Strychnos to a first screening and were thé most active against P. falciparum
(3).
Recently, a new screening was carried out on thirteen Strychnos species; methanolic
and EtOAc extracts were tested in vitro against a chloroquine-susceptible line of P.
falciparum which was cultivated according to thé procédure of Trager and Jensen (4). The
assays were performed as described by Desjardin et al. (5) and modified by Mirovsky et al.
(6). No species seemed as active as S. icaja (ICso about 0.3 ug/ml for EtOAc extract of roots)
and S. usambarensis (ICso about 0.5 ug/ml for EtOAc extract of roots). However, four other
species could be interesting for further investigations: S. gossweileri Exell, S. henningsn Gilg,
S. mellodora S. Moore and especially S. variabilis De Wild. (ICso about 2.5 ug/ml for EtOAc
extract of roots).
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